SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
| RIAZOLIN | 0.1 % | Eye drops · Ophthalmic use | 1 Dropper Container | SAR 16.65 | Generic · Prescription | RIYADH PHARMA | Valid |
| ALBALON EYE DROPS 0.1% | 0.1 % | Ear drops, solution · Ocular use | 1 Dropper Container | SAR 14.60 | NCE · Prescription | ALLERGAN PHARMACEUTICALS LTD | Withdrawn by MAH · Not Marketed |
| APIZOLIN 0.1% EYE DROP | 0.1 % | Ear drops, solution · Ocular use | 1 Dropper Container | SAR 3.85 | Generic · Prescription | Amman Pharmaceutical Industries (API) | Withdrawn by MAH · Not Marketed |
| KONJUNCTIVAL EYE DROPS | 0.1 % | Eye drops · Ophthalmic use | 1 Dropper Container | SAR 11.90 | NCE · OTC | DR. THILO LABORATORIES | Withdrawn by MAH · Not Marketed |
| MURINE EYE DROPS | 0.012 % | Eye drops · Ocular use | 1 Dropper Container | SAR 3.70 | Generic · OTC | Abbott Laboratories | Withdrawn by MAH · Not Marketed |
| NAPHCON FORTE 0.1% EYE DROPS | 0.1 % | Ear drops, solution · Ocular use | 1 Dropper Container | SAR 17.30 | Generic · Prescription | ALCON COUVREUR | Withdrawn by MAH · Not Marketed |
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
| VASOCON | 0.1% | solution/drops · ophthalmic | NOVARTIS | Discontinued | 7 Jun 1971 |
| ALBALON | 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | solution/drops · ophthalmic | ALLERGAN | Discontinued | 24 Mar 1972 |
| NAPHCON FORTE | 0.1% | solution/drops · ophthalmic | ALCON | Discontinued | 6 Mar 1974 |
| NAPHAZOLINE HYDROCHLORIDE | 0.1% | solution/drops · ophthalmic | RISING | Discontinued | 22 Aug 1974 |
| OPCON | 0.1% | solution/drops · ophthalmic | BAUSCH AND LOMB | Discontinued | 1 Dec 1981 |
| NAFAZAIR | 0.1% | solution/drops · ophthalmic | BAUSCH AND LOMB | Discontinued | 25 May 1994 |
| NAFAZAIR | 0.1% | solution/drops · ophthalmic | PHARMAFAIR | Discontinued | |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
| CLEAR EYES | 02248060 | 0.012 % | LIQUID · OPHTHALMIC | PRESTIGE BRANDS INC |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
| NHS Drug Tariff | Naphazoline 0.012% eye drops | £3.49 | 10 ml | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Combinations containing Naphazoline
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.